Literature DB >> 29671247

Histopathological features to define atypical meningioma: What does really matter for prognosis?

Valeria Barresi1, Simona Lionti2, Samuel Caliri2, Maria Caffo3.   

Abstract

Atypical meningiomas are diagnosed in the presence of: (1) three or more of the following minor atypical criteria: increased cellularity, small cells with a high nuclear/cytoplasmic ratio, prominent nucleoli, sheeting, and foci of spontaneous or geographic necrosis; (2) mitotic count ≥ 4 mitoses per 10 HPF (high mitotic index); (3) brain invasion. The 5-year disease-free survival (DFS) is around 50%. Due to their heterogeneous behavior, the post-surgical treatment of atypical meningiomas is controversial. This study investigated the ability of histopathological features to predict recurrence risk of atypical meningiomas. Meningiomas classified as atypical only on minor atypical criteria had low recurrence risk. Brain invasion, high mitotic index and sheeting were significantly associated with shorter disease-free survival (DFS) (P = 0.001; P = 0.01; P = 0.01). The presence of brain invasion and the co-presence of sheeting and high mitotic index had the highest ability to identify recurring meningiomas (P = 0.0001) (sensitivity: 90.9%; specificity: 86.7%). Our results suggest reconsideration of classification of meningiomas as atypical based only on minor atypical criteria. The presence of brain invasion and the co-occurrence of sheeting and high mitotic count may be useful to identify high risk cases, which may benefit from adjuvant treatments.

Entities:  

Keywords:  Atypical meningioma; Brain invasion; Grading; Mitotic index; Sheeting

Mesh:

Year:  2018        PMID: 29671247     DOI: 10.1007/s10014-018-0318-z

Source DB:  PubMed          Journal:  Brain Tumor Pathol        ISSN: 1433-7398            Impact factor:   3.298


  16 in total

Review 1.  Prognostic significance of brain invasion in meningiomas: systematic review and meta-analysis.

Authors:  Satoshi Nakasu; Yoko Nakasu
Journal:  Brain Tumor Pathol       Date:  2021-01-06       Impact factor: 3.298

2.  Histopathological predictors of progression-free survival in atypical meningioma: a single-center retrospective cohort and meta-analysis.

Authors:  Min-Sung Kim; Se-Woong Chun; Yun-Sik Dho; Youngbeom Seo; Joo Ho Lee; Jae Kyung Won; Jin Wook Kim; Chul-Kee Park; Sung-Hye Park; Yong Hwy Kim
Journal:  Brain Tumor Pathol       Date:  2022-01-15       Impact factor: 3.298

3.  Efficient Prediction of Ki-67 Proliferation Index in Meningiomas on MRI: From Traditional Radiological Findings to a Machine Learning Approach.

Authors:  Yanjie Zhao; Jianfeng Xu; Boran Chen; Le Cao; Chaoyue Chen
Journal:  Cancers (Basel)       Date:  2022-07-26       Impact factor: 6.575

4.  Clinical and pathological impact of an optimal assessment of brain invasion for grade 2 meningioma diagnosis: lessons from a series of 291 cases.

Authors:  Thiébaud Picart; Chloé Dumot; Jacques Guyotat; Vladislav Pavlov; Nathalie Streichenberger; Alexandre Vasiljevic; Tanguy Fenouil; Anne Durand; Emmanuel Jouanneau; François Ducray; Timothée Jacquesson; Moncef Berhouma; David Meyronet
Journal:  Neurosurg Rev       Date:  2022-04-29       Impact factor: 2.800

5.  A Novel Scoring System Based on Preoperative Routine Blood Test in Predicting Prognosis of Atypical Meningioma.

Authors:  Xiaoyong Chen; Guojun Wang; Jianhe Zhang; Gaoqi Zhang; Yuanxiang Lin; Zhangya Lin; Jianjun Gu; Dezhi Kang; Chenyu Ding
Journal:  Front Oncol       Date:  2020-09-04       Impact factor: 6.244

6.  Fibulin-2: A Novel Biomarker for Differentiating Grade II from Grade I Meningiomas.

Authors:  Agbolahan A Sofela; David A Hilton; Sylwia Ammoun; Daniele Baiz; Claire L Adams; Emanuela Ercolano; Michael D Jenkinson; Kathreena M Kurian; Mario Teo; Peter C Whitfield; Felix Sahm; C Oliver Hanemann
Journal:  Int J Mol Sci       Date:  2021-01-08       Impact factor: 5.923

7.  The histopathological diagnosis of atypical meningioma: glass slide versus whole slide imaging for grading assessment.

Authors:  Serena Ammendola; Elena Bariani; Albino Eccher; Arrigo Capitanio; Claudio Ghimenton; Liron Pantanowitz; Anil Parwani; Ilaria Girolami; Aldo Scarpa; Valeria Barresi
Journal:  Virchows Arch       Date:  2020-12-10       Impact factor: 4.064

8.  Establishment and Validation of an Integrated Model to Predict Postoperative Recurrence in Patients With Atypical Meningioma.

Authors:  Xiao-Yong Chen; Jin-Yuan Chen; Yin-Xing Huang; Jia-Heng Xu; Wei-Wei Sun; Yue- Chen; Chen-Yu Ding; Shuo-Bin Wang; Xi-Yue Wu; De-Zhi Kang; Hong-Hai You; Yuan-Xiang Lin
Journal:  Front Oncol       Date:  2021-10-07       Impact factor: 6.244

9.  Atypical meningioma: a retrospective analysis of six cases and literature review.

Authors:  Yiming Liang; Bo Ning; Xing Hua; Zhiping Liang; Jingchao Ye; Fangyi Yu; Zhilei Xu; Jiaxiang Chen
Journal:  Transl Cancer Res       Date:  2021-03       Impact factor: 1.241

10.  Atypical Histological Features as Risk Factors for Recurrence in Newly Diagnosed WHO Grade I Meningioma.

Authors:  Keitaro Chiba; Takashi Sugawara; Daisuke Kobayashi; Akihito Sato; Yasuhiro Murota; Taketoshi Maehara
Journal:  Neurol Med Chir (Tokyo)       Date:  2021-09-01       Impact factor: 1.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.